Triangle Securities Wealth Management’s Vanguard Health Care ETF VHT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.44M | Sell |
4,825
-76
| -2% | -$21.1K | 0.29% | 83 |
|
|
2026
Q1 | $1.33M | Buy |
4,901
+261
| +6% | +$74.6K | 0.3% | 83 |
|
|
2025
Q4 | $1.34M | Buy |
4,640
+309
| +7% | +$86.3K | 0.28% | 86 |
|
|
2025
Q3 | $1.12M | Sell |
4,331
-88
| -2% | -$22.1K | 0.25% | 102 |
|
|
2025
Q2 | $1.1M | Buy |
4,419
+253
| +6% | +$62.5K | 0.27% | 93 |
|
|
2025
Q1 | $1.1M | Buy |
4,166
+58
| +1% | +$15.5K | 0.28% | 96 |
|
|
2024
Q4 | $1.04M | Buy |
4,108
+2,065
| +101% | +$556K | 0.27% | 95 |
|
|
2024
Q3 | $577K | Buy |
2,043
+138
| +7% | +$38.3K | 0.15% | 144 |
|
|
2024
Q2 | $507K | Buy |
1,905
+114
| +6% | +$29.9K | 0.14% | 145 |
|
|
2024
Q1 | $485K | Buy |
1,791
+192
| +12% | +$50.4K | 0.14% | 145 |
|
|
2023
Q4 | $401K | Buy |
1,599
+75
| +5% | +$17.8K | 0.12% | 153 |
|
|
2023
Q3 | $358K | Buy |
1,524
+50
| +3% | +$12.2K | 0.13% | 151 |
|
|
2023
Q2 | $361K | Buy |
1,474
+20
| +1% | +$4.87K | 0.12% | 156 |
|
|
2023
Q1 | $347K | Buy |
1,454
+70
| +5% | +$16.8K | 0.12% | 157 |
|
|
2022
Q4 | $343K | Sell |
1,384
-10
| -0.7% | -$2.42K | 0.13% | 158 |
|
|
2022
Q3 | $312K | Hold |
1,394
| – | – | 0.13% | 154 |
|
|
2022
Q2 | $328K | Buy |
1,394
+29
| +2% | +$6.99K | 0.13% | 150 |
|
|
2022
Q1 | $347K | Hold |
1,365
| – | – | 0.12% | 152 |
|
|
2021
Q4 | $364K | Buy |
1,365
+175
| +15% | +$44.6K | 0.11% | 152 |
|
|
2021
Q3 | $294K | Sell |
1,190
-110
| -8% | -$28.2K | 0.1% | 155 |
|
|
2021
Q2 | $321K | Buy |
1,300
+1
| +0.1% | +$239 | 0.11% | 158 |
|
|
2021
Q1 | $297K | Buy |
+1,299
| New | +$298K | 0.11% | 155 |
|
|
2020
Q1 | – | Sell |
-1,223
| Closed | -$234K | – | 167 |
|
|
2019
Q4 | $234K | Buy |
+1,223
| New | +$219K | 0.1% | 148 |
|
|
2018
Q4 | – | Sell |
-1,145
| Closed | -$207K | – | 146 |
|
|
2018
Q3 | $207K | Buy |
+1,145
| New | +$197K | 0.11% | 137 |
|
|
2016
Q2 | – | Sell |
-1,682
| Closed | -$207K | – | 134 |
|
|
2016
Q1 | $207K | Sell |
1,682
-64,465
| -97% | -$7.84M | 0.14% | 131 |
|
|
2015
Q4 | $7.4M | Buy |
66,147
+64,466
| +3,835% | +$8.4M | 4.96% | 2 |
|
|
2015
Q3 | $206K | Buy |
1,681
+1
| +0.1% | +$137 | 0.16% | 129 |
|
|
2015
Q2 | $235K | Hold |
1,680
| – | – | 0.17% | 124 |
|
|
2015
Q1 | $228K | Hold |
1,680
| – | – | 0.16% | 129 |
|
|
2014
Q4 | $211K | Sell |
1,680
-139
| -8% | -$17.1K | 0.15% | 132 |
|
|
2014
Q3 | $213K | Hold |
1,819
| – | – | 0.16% | 116 |
|
|
2014
Q2 | $203K | Buy |
+1,819
| New | +$195K | 0.16% | 125 |
|
|
2013
Q3 | – | Sell |
-2,135
| Closed | -$184K | – | 374 |
|
|
2013
Q2 | $184K | Buy |
+2,135
| New | +$184K | 0.14% | 122 |
|
Other funds holding VHT
AAG
CA
CMA
LFP
MAM
BI
DAS
MPWT
FFN
Triangle Securities Wealth Management's VHT Position: Q2 2026 in Review
Triangle Securities Wealth Management reduced its Vanguard Health Care ETF (VHT) stake by 1.6% in Q2 2026, selling an estimated $21.1K and leaving 4,825 shares worth $1.44M. The position accounts for 0.29% of the portfolio, ranked #83.
Triangle Securities Wealth Management first reported a position in VHT in Q2 2013 and has held it in 33 quarters since. The position peaked at $7.4M in Q4 2015. 180 funds tracked by Wall St. Rank hold VHT as of Q2 2026.
- Triangle Securities Wealth Management held 4,825 shares of Vanguard Health Care ETF worth $1.44M as of Q2 2026.
- Triangle Securities Wealth Management sold 76 Vanguard Health Care ETF shares in Q2 2026, an estimated $21.1K.
- Vanguard Health Care ETF made up 0.29% of Triangle Securities Wealth Management's portfolio in Q2 2026, its #83 holding.
- Triangle Securities Wealth Management first reported a position in Vanguard Health Care ETF in Q2 2013 and has held it in 33 quarters since.
- Triangle Securities Wealth Management's Vanguard Health Care ETF position peaked at $7.4M in Q4 2015.
- 180 funds tracked by Wall St. Rank held Vanguard Health Care ETF as of Q2 2026.
Based on Triangle Securities Wealth Management's 13F filing for Q2 2026, filed 14 Jul 2026.